Pharmafile Logo

The dissemination and consumption of medical literature is evolving

QxMD, part of the WebMD Health Network discusses how they are going to evolve its publication solution, Read by QxMD in 2023.

- PMLiVE

Traditionally, new scientific data would be presented at specialist congresses, subsequently published in a peer-reviewed journal and finally referenced in guidelines (if deemed practicing changing). As with many things, this has been shaken up in the last decade.¹ Not only is there now a LOT more medical literature,²,³ but there are more opportunities to see and discuss that data at various points along the publishing journey. This is apparent at both ends of the spectrum.

We’ve discussed before how it is now common for a paper to be posted on a preprint server ahead of being published in a peer-reviewed journal or presented at a congress.⁴,⁵ While at the other end of the spectrum, a surge in social media and platforms that connect the medical community mean the discussion and analysis continue long after a paper is published or presented. This is great, it’s democratizing information and encouraging people to share their insights and experiences. It’s also pretty overwhelming. In the past you could get away with following a few key journals but now there are too many different sources, formats and voices.

With all this in mind, we have been working hard to ensure you can access research in all its different forms through Read by QxMD. One place to access everything you need, but filtered and focused according to your interests, your preferences and your habits.

Since April this year we have been indexing preprints from Research Square, MedRxiv and Biorxiv. As a pilot, we initially did this for just Cardiology, Neurology, Endocrinology and Oncology. So far 1,761 people have viewed 5,864 preprints through Read by QxMD and some of our wonderful contributors have created collections showcasing the best of the best for their specialty. In 2023 we are considering rolling this out into other specialties but we need to know if you think it’s a useful addition and would like to see them for your specialty!

Things may be evolving but for the majority, congresses are still the place to go for cutting edge information. This is the case for researchers looking to disseminate their work — with 81% using academic conferences for this purpose. It’s also the case for those looking for info on the latest research — with 63% indicating a preference for conferences.

We are working with our partners MedscapeLIVE! to index abstracts for their conferences. We’ve done this for 8 conferences this year, events like the Neurology Exchange, The Annual T-Cell Lymphoma Forum, Psychiatry Winter Update and we will be doing even more in 2023. Again, in time, we hope to roll this out beyond MedscapeLIVE! conferences.

We have a unique license to index all information from PubMed — as soon as it appears on PubMed it appears on QxMD. This is the core of what we provide and will remain so as being published in a peer-reviewed journal is still the gold standard for any new research. Reinforced by the fact that 96% of papers viewed on Read by QxMD in November were journal articles. Not only does Read suggest papers relevant for you and allow you to follow specific journals, as long as you connect to your institution you will have access to full text articles within the app, through your institution subscriptions.

You hopefully saw our recent article announcing our new partnership with 2MM — an award winning study summary service that provides physician-authored summaries of the latest, high-impact, clinical trials. We only launched these in October but we’re already seeing great numbers. In November alone, 10,160 study summaries were viewed on Read by QxMD!

In a year, QxMD has evolved to give you better access to research in all its forms. All from within the same app, with the same familiar user experience and most importantly, our algorithm is working harder than ever to understand your preferences and habits, and give you research focused and filtered for you. So even for the 40% of physicians who only have 15 minutes a day to read research,⁶ we can help you make the most of those 15 minutes.

You can get more information on QxMD Read here.  Or contact us directly to discuss here.

References

  1. https://journals.lww.com/jphmp/fulltext/2018/03000/getting_the_word_out__new_approaches_for.4.aspx#:~:text=As%20noted%20previously%2C%20academic%20journals,which%20researchers%20disseminate%20their%20research
  2. https://read.qxmd.com/read/35776372/revisiting-the-time-needed-to-provide-adult-primary-care
  3. https://read.qxmd.com/read/34619981/keeping-up-with-the-medical-literature-why-how-and-when
  4. https://read.qxmd.com/read/35031791/rise-of-the-preprint-how-rapid-data-sharing-during-covid-19-has-changed-science-forever
  5. https://onlinelibrary.wiley.com/doi/full/10.1002/leap.1402
  6. https://c8y.doxcdn.com/image/upload/Press%20Blog/Research%20Reports/Doximity-Physician-Learning-Report-2022.pdf

About  Medscape Medical Affairs 
Medscape Medical Affairs partners with Medical Affairs teams throughout a product’s lifecycle. We facilitate optimal collaboration between internal teams, physicians, and the broader medical community, connecting you directly with Medscape’s +5 million active physician members worldwide. Medscape Medical Affairs is a subsidiary of WebMD Health Corp.

About WebMD Health Corp.
WebMD Health Corp., an Internet Brands Company, is the leading provider of health information services, serving patients, physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, prIME Oncology, MediQuality, Frontline, Vitals Consumer Services, Aptus Health, MedicineNet, eMedicineHealth, RxList, OnHealth, Medscape Education, and other owned WebMD sites. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

This content was provided by Medscape Medical Affairs

Company Details

 Latest Content from  Medscape Medical Affairs 

Medscape Medical Affairs Celebrate a High Commendation at the PMEAs

Last night the Medscape Medical Affairs team gathered in London for the Pharmaceutical Marketing Excellence Awards (PMEAs) where their entries, Transatlantic Exchanges: Artificial Intelligence and Data Science in Oncology and...

Medscape Medical Affairs Selected as Finalist for 2023 Pharmaceutical Market Excellence Awards (PMEAs)

We’re delighted to announce that two Global Medscape Medical Affairs programmes have been shortlisted in various categories for The Pharmaceutical Market Excellence Awards (PMEAs). The two programmes selected both succeeded...

Medscape Medical Affairs is Advancing Equity in Clinical Trials

Clinical trials are not just a necessary step in bringing a new drug or device to market, but a crucial investment on the part of the developing company. By 2025,...

Medscape Medical Affairs celebrate a double win at the Communiqué Awards 2023

Medscape Medical Affairs celebrates a remarkable achievement with a double win at the prestigious Communiqué Awards 2023.

Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards

We’re delighted to announce that two Medscape Medical Affairs programs have been selected across different categories as finalists for the 2023 Communiqué Awards. The two programs selected were designed to...

Intelligent and powerful Data/Publication Dissemination with Read, by QxMD

You can get more information on QxMD Read here.  Or contact us directly to discuss here.

The dissemination and consumption of medical literature is evolving

QxMD, part of the WebMD Health Network discusses how they are going to evolve its publication solution, Read by QxMD in 2023.

Medscape Medical Affairs Celebrate a Double Win at the PMEAs

Last night the Medscape Medical Affairs team gathered in London for the Pharmaceutical Market Excellence Awards (PMEAs) where their entry, Transatlantic Exchanges: Driving Therapeutic Innovation in Oncology for the Benefit of...

Actionable Insights for Medical Affairs: Elusive or Within Reach?

Plato was right: Necessity is the mother of invention, and — in the case of Medical Affairs departments — the driving force behind their creation was the federally mandated separation...

Medscape Medical Affairs are PMEA Finalists in Three Categories

The Pharmaceutical Market Excellence Awards (PMEA) have announced that Medscape Medical Affairs is a finalist in their 2022 awards for their entry Transatlantic Exchanges: Driving Therapeutic Innovation in Oncology for...